Alpha 2.0
Login Register
» Authors » Catherine Stansfield

Catherine Stansfield

Explore the profile of Catherine Stansfield including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 213
Followers 0
Related Specialties
Gastroenterology
Nursing
Pharmacology
Top 10 Co-Authors
Jimmy K Limdi
Shaji Sebastian
Aileen Fraser
Daniel Storey
Catherine Kenneth
Christian P Selinger
Karen Kemp
Francesca Fairhurst
Suzanne Tattersall
Marco Vincenzo Lenti
Published In
Nurs Stand
BMJ Open Gastroenterol
J Res Nurs
Dig Liver Dis
Am J Clin Nutr
Affiliations
Soon will be listed here.
Recent Articles
1.
Disease Recurrence and Long-term Outcomes Following the Development of Intestinal Failure in Crohn's Disease: Over 20 Years of Experience from a National Reference Centre
Kopczynska M, Crooks B, Deutsch L, Conley T, Stansfield C, Bond A, et al.
J Crohns Colitis . 2023 Jun; 17(12):1910-1919. PMID: 37343184
Background And Aims: Intestinal failure [IF] is a recognised complication of Crohn's disease [CD]. The aim of this study was to identify factors predicting the development and recurrence of CD...
2.
Commentary: The impact of Inflammatory Bowel Disease related fatigue on Health-Related Quality of Life: a qualitative semi-structured interview study
Stansfield C
J Res Nurs . 2022 Dec; 27(8):703. PMID: 36530742
No abstract available.
3.
A propensity score-matched, real-world comparison of ustekinumab vs vedolizumab as a second-line treatment for Crohn's disease. The Cross Pennine study II
Lenti M, Dolby V, Clark T, Hall V, Tattersall S, Fairhurst F, et al.
Aliment Pharmacol Ther . 2021 Dec; 55(7):856-866. PMID: 34935160
Background: The optimal choice of biological agents after failure of anti-tumour-necrosis-factor-(TNF)α agent in Crohn's disease (CD) is yet to be defined. Aims: To assess the effectiveness and safety of ustekinumab...
4.
Food-related quality of life is impaired in inflammatory bowel disease and associated with reduced intake of key nutrients
Whelan K, Murrells T, Morgan M, Cummings F, Stansfield C, Todd A, et al.
Am J Clin Nutr . 2021 Mar; 113(4):832-844. PMID: 33677550
Background: Inflammatory bowel disease (IBD) may impact the extent to which food, eating, and drinking bring satisfaction and enjoyment to peoples' lives, and this may impact dietary intake. The prevalence...
5.
Ferric maltol Real-world Effectiveness Study in Hospital practice (FRESH): clinical characteristics and outcomes of patients with inflammatory bowel disease receiving ferric maltol for iron-deficiency anaemia in the UK
Cummings J, Fraser A, Stansfield C, Beales I, Sebastian S, Hoque S
BMJ Open Gastroenterol . 2021 Feb; 8(1). PMID: 33622683
Objective: To assess outcomes in patients with iron-deficient inflammatory bowel disease (IBD) treated with ferric maltol in UK real-world practice. Design/method: This observational, multicentre, retrospective cohort study included adults with...
6.
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
Kennedy N, Jones G, Lamb C, Appleby R, Arnott I, Beattie R, et al.
Gut . 2020 Apr; 69(6):984-990. PMID: 32303607
The COVID-19 pandemic is putting unprecedented pressures on healthcare systems globally. Early insights have been made possible by rapid sharing of data from China and Italy. In the UK, we...
7.
A real-world, long-term experience on effectiveness and safety of vedolizumab in adult patients with inflammatory bowel disease: The Cross Pennine study
Lenti M, Levison S, Eliadou E, Willert R, Kemp K, Carter A, et al.
Dig Liver Dis . 2018 Aug; 50(12):1299-1304. PMID: 30077465
Background: Real-life data on vedolizumab effectiveness in inflammatory bowel disease (IBD) are still emerging. Data on the comparative safety of the gut selective profile are of particular interest. Aims: To...
8.
Nutrition in hospital
Stansfield C
Nurs Stand . 2016 Jan; 30(21):61-2. PMID: 26786463
Many people aged over 65 in acute hospitals have dementia. When older people are ill, they are at increased risk of malnourishment because of reduced appetite.